Covaxin demonstrated excellent safety record during studies: Bharat Biotech
Bharat Biotech said on Thursday its Covid-19 vaccine, Covaxin, had demonstrated an excellent track record during several studies that had been conducted on its safety and published in peer-reviewed journals. The statement of the company that developed …